Project Grant R01HL180886
Award Date 9/1/26
Completion Date 5/31/31
Dollars Obligated $682K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Hershey, PA 17033, USA
Similar Awards
- The National Institute of Neurological Disorders and Stroke awarded Pennsylvania State University, operating as Penn State Milton S. Hershey Medical Center, $585,999 on June 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate cerebellothalamocortical communication and its role in cerebellar dysfunction. The research employs in vitro and in vivo experiments to characterize how the thalamus dynamically regulates...
- The National Institute of Child Health and Human Development awarded Pennsylvania State University, operating as Penn State Milton S. Hershey Medical Center, $170,851 on June 1, 2026, for a project grant under the Child Health and Human Development Extramural Research program (CFDA 93.865). The recipient will engage stakeholders to optimize an evidence-based transdiagnostic sleep and circadian intervention for autistic adults ages 18–65. Aim 1 involves iteratively adapting the Transdiagnostic...
- The National Heart, Lung, and Blood Institute awarded The Trustees of the University of Pennsylvania $1.542 million on September 15, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to improve understanding of sleep apnea pathogenesis using novel imaging techniques during sleep. The research combines drug-induced sleep endoscopy (DISE) with dynamic magnetic resonance imaging (MRI) to characterize upper airway anatomy and the mechanisms of airway collapse during sleep. The...
- The National Institute of Mental Health awarded Pennsylvania State University (Penn State Milton S. Hershey Medical Center) $704,700 on May 22, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and pilot a transdiagnostic sleep and circadian intervention adapted for autistic adolescents and young adults ages 12–25. The project adapts TRANS-C (Transdiagnostic Intervention for Sleep and Circadian Dysfunction), an existing evidence-based sleep intervention, to address...
- The National Heart, Lung, and Blood Institute awarded Pennsylvania State University (operating as Penn State Milton S. Hershey Medical Center) $777,903 on August 4, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop software tools and statistical methods for dissecting functional and environment-dependent effects of lipid-associated genetic variants. The award funds development of novel computational approaches to integrate experimental genomic data and refine...
- The National Heart, Lung, and Blood Institute awarded Texas A&M University $2.214 million on September 11, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate the role of GPI-anchor biosynthesis in sleep regulation. The project applies genomic, computational, and behavioral approaches to functionally validate sleep genes identified through human genome-wide association studies. The work includes identifying targets of the GPI-anchor biosynthesis pathway in...
- The National Institute of Neurological Disorders and Stroke awarded The Trustees of The University of Pennsylvania $243,750 on February 11, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds single-nucleus gene expression and chromatin accessibility profiling to identify and characterize neuronal heterogeneity in the murine hypothalamus during sleep and wake states. The research applies single-nucleus RNA sequencing...
- The National Heart, Lung, and Blood Institute awarded Emory University $100,228 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct longitudinal research examining associations between sleep health, protective factors against psychosocial adversity, and stress-related biomarkers including allostatic load and epigenetic age acceleration. The project analyzes multidimensional sleep health—encompassing regularity, satisfaction, alertness, timing,...
- The National Heart, Lung, and Blood Institute awarded the University of Pennsylvania $254,026 on September 30, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to support Dr. Nathan Nowalk's postdoctoral research training in metabolic endpoints for obstructive sleep apnea following hypoglossal nerve stimulation therapy. Dr. Nowalk, a sleep medicine research fellow at the University of Chicago, will develop expertise in advanced statistical analyses of glucose metabolism and...
- The National Heart, Lung, and Blood Institute awarded the University of North Carolina at Chapel Hill $166,248 on September 26, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct research triangulating causal effects of sleep, inflammation, and cardiometabolic disease. The research will identify oxylipin biomarkers associated with sleep problems—including insomnia, sleep apnea, and short sleep duration—and their relationship to cardiometabolic disease. The study...